Activity Change of Sphingomyelin Catabolic Enzymes during Dimethylnitrosamine-induced Hepatic Fibrosis in Rats

  • Sacket, Santosh J. (Laboratory of Pharmacology, College of Pharmacy (BK21 Project) and Longevity Life Science and Technology Institutes, Pusan National University) ;
  • Im, Dong-Soon (Laboratory of Pharmacology, College of Pharmacy (BK21 Project) and Longevity Life Science and Technology Institutes, Pusan National University)
  • Published : 2008.03.28


Oxidative stress may represent a common link between chronic liver damage and hepatic fibrosis. In the present study, we investigated activity changes of sphingomyelin catabolic enzymes, such as sphingomyelinases and ceramidases by using dimethylnitrosamine (DMN)-treated Sprague-Dawley (SD) male rats hepatic fibrosis model as a hepatic fibrosis model. Twenty rats divided into five groups received: (1) saline; (2) DMN for 1 week, (3) DMN for 2 weeks, (4) DMN for 3 weeks, and (5) DMN for 4 weeks by intraperitoneally 10 mg/kg of body weight for three consecutive days a week. Activities of acidic and neutral sphingomyelinases and acidic, neutral and alkaline ceramidases were measured in the liver and kidney from DMN-treated rats. We found increased ceramidase activities from 2-week and/or 3-week DMN treated rat livers compared to control rat liver. Acidic sphingomyelinase and alkaline ceramidase activities were significantly increased in 3-week DMN-treated rat kidneys compared to control rat kidney. Therefore, sphingolipid metabolizing enzymes and sphingolipid metabolites are supposed to be involved in liver fibrosis, although further investigation is necessary to elucidate meanings of sphingolipids during the liver fibrosis



  1. Chalfant, C. E., Rathman, K., Pinkerman, R. L., Wood, R. E., Obeid, L. M., Ogretmen, B. and Hannun, Y. A. (2002). De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1. J Biol Chem 277, 12587-12595
  2. Chen, J., Nikolova-Karakashian, M., Merrill, A. H., Jr. and Morgan, E. T. (1995). Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes. J Biol Chem 270, 25233-25238
  3. Chun, Y. J., Park, S. and Yang, S. A. (2003). Activation of Fas receptor modulates cytochrome P450 3A4 expression in human colon carcinoma cells. Toxicol Lett 146, 75-81
  4. Cock, J. G., Tepper, A. D., de Vries, E., van Blitterswijk, W. J. and Borst, J. (1998). CD95 (Fas/APO-1) induces ceramide formation and apoptosis in the absence of a functional acid sphingomyelinase. J Biol Chem 273, 7560- 7565
  5. Cuvillier, O. and Levade, T. (2003). Enzymes of sphingosine metabolism as potential pharmacological targets for therapeutic intervention in cancer. Pharmacol Res 47, 439-445
  6. Friedman, S. L. (1993). Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328, 1828-1835
  7. George, J. and Chandrakasan, G. (1996). Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagen. Biochim Biophys Acta 1292, 215-222
  8. George, J., Rao, K. R., Stern, R. and Chandrakasan, G. (2001). Dimethylnitrosamine-induced liver injury in rats: the early deposition of collagen. Toxicology 156, 129- 138
  9. Haggerty, H. G. and Holsapple, M. P. (1990). Role of metabolism in dimethylnitrosamine-induced immunosuppression: a review. Toxicology 63, 1-23
  10. Hannun, Y. A. (1996). Functions of ceramide in coordinating cellular responses to stress. Science 274, 1855- 1859
  11. Hannun, Y. A., Luberto, C. and Argraves, K. M. (2001). Enzymes of sphingolipid metabolism: from modular to integrative signaling. Biochemistry 40, 4893-4903
  12. Hashimoto, N., Ishikawa, Y. and Utsunomiya, J. (1989). Effects of portacaval shunt, transposition, and dimethylnitrosamine- induced chronic liver injury on pancreatic hormones and amino acids in dog. J Surg Res 46, 35-40
  13. Igarashi, Y. and Hakomori, S. (1989). Enzymatic synthesis of N,N-dimethyl-sphingosine: demonstration of the sphingosine: N-methyltransferase in mouse brain. Biochem Biophys Res Commun 164, 1411-1416
  14. Iredale, J. P. (2007). Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest 117, 539-548
  15. Jenkins, S. A., Grandison, A., Baxter, J. N., Day, D. W., Taylor, I. and Shields, R. (1985). A dimethylnitrosamineinduced model of cirrhosis and portal hypertension in the rat. J Hepatol 1, 489-499
  16. Jezequel, A. M., Mancini, R., Rinaldesi, M. L., Macarri, G., Venturini, C. and Orlandi, F. (1987). A morphological study of the early stages of hepatic fibrosis induced by low doses of dimethylnitrosamine in the rat. J Hepatol 5, 174-181
  17. Jezequel, A. M., Mancini, R., Rinaldesi, M. L., Ballardini, G., Fallani, M., Bianchi, F. and Orlandi, F. (1989). Dimethylnitrosamine- induced cirrhosis. Evidence for an immunological mechanism. J Hepatol 8, 42-52
  18. Kim, Y., Ratziu, V., Choi, S. G., Lalazar, A., Theiss, G., Dang, Q., Kim, S. J. and Friedman, S. L. (1998). Transcriptional activation of transforming growth factor beta1 and its receptors by the Kruppel-like factor Zf9/core promoter- binding protein and Sp1. Potential mechanisms for autocrine fibrogenesis in response to injury. J Biol Chem 273, 33750-33758
  19. Kolesnick, R. (2002). The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110, 3-8
  20. Lee, M. H., Yoon, S. and Moon, J. O. (2004). The flavonoid naringenin inhibits dimethylnitrosamine-induced liver damage in rats. Biol Pharm Bull 27, 72-76
  21. Li, D. and Friedman, S. L. (1999). Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy. J Gastroenterol Hepatol 14, 618-633
  22. Liu, B. and Hannun, Y. A. (2000). Sphingomyelinase assay using radiolabeled substrate. Methods Enzymol 311, 164-167
  23. Mancini, R., Jezequel, A. M., Benedetti, A., Paolucci, F., Trozzi, L. and Orlandi, F. (1992). Quantitative analysis of proliferating sinusoidal cells in dimethylnitrosamineinduced cirrhosis. An immunohistochemical study. J Hepatol 15, 361-366
  24. Mathias, S., Pena, L. A. and Kolesnick, R. N. (1998). Signal transduction of stress via ceramide. Biochem J 335 (Pt 3), 465-480
  25. Nikolova-Karakashian, M. and Merrill, A. H., Jr. (2000). Ceramidases. Methods Enzymol 311, 194-201
  26. Obeid, L. M. and Hannun, Y. A. (2003). Ceramide, stress, and a 'LAG' in aging. Sci Aging Knowledge Environ 2003, PE27
  27. Paolucci, F., Mancini, R., Marucci, L., Benedetti, A., Jezequel, A. M. and Orlandi, F. (1990). Immunohistochemical identification of proliferating cells following dimethylnitrosamine- induced liver injury. Liver 10, 278-281
  28. Roberts, R. A., Ganey, P. E., Ju, C., Kamendulis, L. M., Rusyn, I. and Klaunig, J. E. (2007). Role of the Kupffer cell in mediating hepatic toxicity and carcinogenesis. Toxicol Sci 96, 2-15
  29. Shiba, M., Shimizu, I., Yasuda, M., Ii, K. and Ito, S. (1998). Expression of type I and type III collagens during the course of dimethylnitrosamine-induced hepatic fibrosis in rats. Liver 18, 196-204

Cited by

  1. Tricyclic Antidepressants Promote Ceramide Accumulation to Regulate Collagen Production in Human Hepatic Stellate Cells vol.7, 2017,
  2. Activity Change of Sphingomyelin Anabolic Enzymes during Dimethylnitrosamine-induced Hepatic Fibrosis in Rats vol.16, pp.3, 2008,
  3. New incompatible pair of TCM: Epimedii Folium combined with Psoraleae Fructus induces idiosyncratic hepatotoxicity under immunological stress conditions vol.14, pp.1, 2008,